Health
SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months – News-Medical.Net
A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated…
As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are seeking to identify the protective impact of prior infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
…
-
Noosa News16 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family
-
Noosa News8 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General14 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
General23 hours agoIndonesia airdropped aid for Palestinians in Gaza, but experts question its effectiveness